SCHEMBL27723886

SCHEMBL27723886

CCCC(=O)ON1C(=O)C(=O)c2ccccc21

nearest known ligand 0.58

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CES1 P23141 8/20 0.58
▸ ALDH1A1 P00352 5/20 0.47
▸ AGTR1 P30556 1/20 0.47
▸ ALDH2 P05091 1/20 0.46
▸ ALDH3A1 P30838 1/20 0.46
▸ CDC25A P30304 1/20 0.44
▸ TTR P02766 1/20 0.44
▸ BCHE P06276 1/20 0.42
▸ TGM2 P21980 1/20 0.42
▸ CTRB1 P17538 1/20 0.42
▸ KMT2A Q03164 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ TP53 P04637 2/20 0.40
▸ MAPT P10636 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27703399 0.88 CES1 (0.56) CES1ALDH1A1AGTR1ALDH2ALDH3A1
SCHEMBL3678891 0.83 ALDH1A1 (0.50) CES1ALDH1A1KMT2AMEN1MAPT
SCHEMBL25707100 0.82 CES1 (0.50) CES1ALDH1A1AGTR1TTRBCHE
SCHEMBL28476821 0.82 ALDH1A1 (0.55) CES1ALDH1A1AGTR1KMT2AMEN1
SCHEMBL27703278 0.81 ALDH3A1 (0.43) CES1ALDH1A1AGTR1ALDH2ALDH3A1
SCHEMBL25706975 0.81 CES1 (0.46) CES1ALDH1A1AGTR1ALDH2ALDH3A1
SCHEMBL10800205 0.80 CES1 (0.57) CES1ALDH1A1AGTR1ALDH2ALDH3A1
SCHEMBL13725997 0.79 CES1 (0.51) CES1ALDH1A1AGTR1ALDH2ALDH3A1
SCHEMBL27839876 0.78 CES1 (0.56) CES1ALDH1A1AGTR1ALDH2ALDH3A1
SCHEMBL27703282 0.78 CES1 (0.38) CES1ALDH1A1TGM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103271906-A Use of spiro-oxindole compounds as therapeutic agents XENON PHARMACEUTICALS INC 2013-09-04 — — CN disclosed
CN-102153562-A Spiro-oxindole compounds and their uses as therapeutic agents XENON PHARMACEUTICALS INC 2011-08-17 — — CN disclosed
CN-101631546-A Use of spiro-indolone compounds as therapeutic agents XENON PHARMACEUTICALS INC 2010-01-20 — — CN disclosed
CN-101213174-A Oxindole compounds and their uses as therapeutic agents XENON PHARMACEUTICALS INC (CA) 2008-07-02 — — CN disclosed
CN-101184761-A Spiro-indolone compounds and their use as therapeutic agents XENON PHARMACEUTICALS INC (CA) 2008-05-21 — — CN disclosed
Send feedback